Androst-4-ene-3-6-17-trione CAS: 2243-06-3

CAS NO: 2243-06-3
Androst-4-ene-3-6-17-trione
Chemical Name: Androst-4-ene-3,6,17-trione
Molecular Formula: C19H24O3
Formula Weight: 300.39
CAS No.: 2243-06-3
Description Review
Description

Androst-4-ene-3,6,17-trione, also known as 6-Oxo or 4-Androstenetrione, is a nutritional supplement that has gained popularity among athletes and bodybuilders for its potential to boost testosterone levels and aid in muscle growth. In this article, we will explore the properties, benefits, and potential side effects of Androst-4-ene-3,6,17-trione.

Introduce this product:

Androst-4-ene-3,6,17-trione is a naturally occurring compound that is found in the human body and is also produced synthetically for use as a nutritional supplement. It is marketed as a testosterone booster and is often used by athletes and bodybuilders to improve athletic performance and aid in muscle growth.

Chemical name:

The chemical name of Androst-4-ene-3,6,17-trione is 4-androstene-3,6,17-trione.

Molecular formula:

The molecular formula of Androst-4-ene-3,6,17-trione is C19H24O3.

Formula weight:

The formula weight of Androst-4-ene-3,6,17-trione is 300.39 g/mol.

CAS No:

The CAS number for Androst-4-ene-3,6,17-trione is 2243-06-3.

Top ten keywords from Google and Synonyms:

  1. Testosterone booster
  2. Muscle growth
  3. Athletic performance
  4. Androst-4-ene-3,6,17-trione benefits
  5. 6-Oxo supplement
  6. 4-Androstenetrione
  7. Natural testosterone booster
  8. Hormone balance
  9. Bodybuilding supplement
  10. Performance-enhancing drug

Health benefits of Androst-4-ene-3,6,17-trione:

Androst-4-ene-3,6,17-trione has been marketed as a natural testosterone booster that can help increase muscle mass and improve athletic performance. It may also have potential benefits for hormonal balance and overall health, though more research is needed to confirm these claims.

Potential effects:

Androst-4-ene-3,6,17-trione may have several potential effects, including increased testosterone levels, improved muscle growth, and enhanced athletic performance. Some users have reported improvements in libido and sexual function while taking this supplement.

Product mechanism:

Androst-4-ene-3,6,17-trione works by inhibiting the conversion of testosterone to estrogen in the body. This can lead to an increase in testosterone levels, which may in turn promote muscle growth and enhance athletic performance.

Safety:

While Androst-4-ene-3,6,17-trione is marketed as a natural supplement, it can still have potential risks and side effects. It is important to consult with a healthcare provider before taking this supplement, especially if you have any existing medical conditions or are taking other medications. Women who are pregnant or breastfeeding should not take Androst-4-ene-3,6,17-trione.

Side effects:

Some potential side effects of Androst-4-ene-3,6,17-trione include acne, hair loss, mood swings, and liver damage. Long-term use of this supplement may also have negative effects on cardiovascular health, including an increased risk of heart disease.

Dosing information:

The dosing of Androst-4-ene-3,6,17-trione will vary depending on the individual and their goals. It is typically taken in cycles, with a recommended dosage of 200-600mg per day for 4-8 weeks followed by a break of 4-8 weeks. Users should follow the recommended dosing guidelines and consult with a healthcare provider before starting the supplement.

Conclusion:

Androst-4-ene-3,6,17-trione is a nutritional supplement that is marketed as a natural testosterone booster and muscle growth aid. While it may have potential benefits for athletes and bodybuilders, it is important to consider potential risks and side effects before starting the supplement. Users should consult with a healthcare provider and follow recommended dosing guidelines to ensure safe and effective use of Androst-4-ene-3,6,17-trione.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code